Simultaneous gut colonization by Klebsiella grimontii and Escherichia coli co-possessing the bla


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 14 03 2022
accepted: 16 05 2022
pubmed: 2 6 2022
medline: 7 7 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Only two plasmid-mediated carbapenemases (KPC-2 and VIM-1) are reported in Klebsiella grimontii. Here, we report two bla

Identifiants

pubmed: 35643963
doi: 10.1007/s10096-022-04462-z
pii: 10.1007/s10096-022-04462-z
pmc: PMC9250482
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1087-1091

Informations de copyright

© 2022. The Author(s).

Références

J Glob Antimicrob Resist. 2022 Mar;28:206-215
pubmed: 35085791
J Antimicrob Chemother. 2021 Apr 13;76(5):1140-1149
pubmed: 33615354
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0072421
pubmed: 34181480
PLoS One. 2020 May 18;15(5):e0233313
pubmed: 32421705
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0057421
pubmed: 34339281
Antimicrob Agents Chemother. 2008 Jul;52(7):2680-2
pubmed: 18426899
Int J Syst Evol Microbiol. 2018 Jan;68(1):377-381
pubmed: 29205126
Front Microbiol. 2018 Sep 11;9:2170
pubmed: 30271396
Antimicrob Agents Chemother. 2015 Oct;59(10):5873-84
pubmed: 26169401
Clin Microbiol Rev. 2022 Jan 19;35(1):e0000621
pubmed: 34851134
Antimicrob Agents Chemother. 2020 Sep 21;64(10):
pubmed: 32718957
J Glob Antimicrob Resist. 2021 Dec;27:267-272
pubmed: 34718203
Microb Drug Resist. 2019 Dec;25(10):1475-1483
pubmed: 31334673
Antimicrob Agents Chemother. 2014 May;58(5):2871-7
pubmed: 24614371

Auteurs

Edgar I Campos-Madueno (EI)

Institute for Infectious Diseases (IFIK), University of Bern, Friedbühlstrasse 51, CH-3001, Bern, Switzerland.
Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.

Carola Mauri (C)

Clinical Microbiology and Virology Unit, A. Manzoni Hospital, Lecco, Italy.

Elisa Meroni (E)

Clinical Microbiology and Virology Unit, A. Manzoni Hospital, Lecco, Italy.

Pablo Porragas Paseiro (PP)

Institute for Infectious Diseases (IFIK), University of Bern, Friedbühlstrasse 51, CH-3001, Bern, Switzerland.

Alessandra Consonni (A)

Clinical Microbiology and Virology Unit, A. Manzoni Hospital, Lecco, Italy.

Francesco Luzzaro (F)

Clinical Microbiology and Virology Unit, A. Manzoni Hospital, Lecco, Italy.

Andrea Endimiani (A)

Institute for Infectious Diseases (IFIK), University of Bern, Friedbühlstrasse 51, CH-3001, Bern, Switzerland. andrea.endimiani@ifik.unibe.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH